DBV Technologies (DBVT) Capital Expenditures (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.24% |
| Dec 31, 2025 | 218.80% |
| Sep 30, 2025 | 178.57% |
| Dec 31, 2024 | -131.57% |
| Sep 30, 2024 | -45.90% |
| Jun 30, 2024 | -45.17% |
| Mar 31, 2024 | 279.26% |
| Dec 31, 2023 | 604.00% |
| Sep 30, 2023 | -69.51% |
| Jun 30, 2023 | 47.75% |
| Mar 31, 2023 | 825.00% |
| Dec 31, 2022 | -96.78% |
| Sep 30, 2022 | 56.72% |
| Jun 30, 2022 | 81.68% |
| Mar 31, 2022 | -85.60% |
| Dec 31, 2021 | 7,100.00% |
| Sep 30, 2021 | 92.40% |
| Jun 30, 2021 | -192.93% |
| Jun 30, 2020 | -24.51% |
| Mar 31, 2020 | -87.24% |
| Dec 31, 2019 | 259.56% |
| Sep 30, 2019 | -68.45% |
| Dec 31, 2018 | -21.47% |
| Sep 30, 2018 | -644.65% |